美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

iShares Neuroscience and Healthcare ETF

39.53

-0.1185-0.30%

盘后：39.45-0.0797-0.20%16:10 EDT

成交量：982

成交额：3.86万

市值：790.59万

市盈率：- -

高：39.53

开：39.11

低：39.11

收：39.65

52周最高：43.01

52周最低：24.58

股本：20.00万

流通股本：20.00万

量比：0.50

换手率：0.49%

股息：0.32

股息率：0.81%

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

事关人形机器人、脑机接口，工信部征求意见

首批基金2026年中期报告出炉看好有色、脑机接口等方向

《柳叶刀·神经病学》刊发阿尔凯默斯Alixorexton治疗1型发作性睡病II期临床积极数据

脑机接口保险，从定制到普惠还有多远

工信部就《国家脑机接口产业标准体系建设指南》公开征求意见。

通化金马与宣武医院签署战略合作推进阿尔茨海默病新药临床与脑卒中管线布局

联影医疗与天津大学发布全球首个磁共振脑机接口全栈式解决方案

算力脑机接口接连入局铁路“跨界”新玩法探路数智化转型

中国经营报

全国首届磁共振脑机接口大会在津举办

联影、天津大学联合发布全球首个磁共振脑机接口全栈式解决方案uMR神观

联影、天津大学联合发布全球首个磁共振脑机接口全栈式解决方案uMR神观

Neko Health 与 Neuralink 合作筛选试验受试者

市场消息：Spotify 首席执行官埃克表示，Neko Health 正与脑机接口公司 Neuralink 开展合作。

Scholar Rock撤回了针对肌肉无力药物的欧洲申报，计划重新提交

福瑞医科(300049.SZ)：公司暂无脑机接口的研究

Scholar Rock控股公司获日本PMDA认可，无需补充临床研究；计划2026年底提交Apitegromab上市申请

Scholar Rock Holding公司撤回欧洲上市申请，计划以替代灌装生产线重新提交

Scholar Rock Holding Corp：蓄势待发，静候FDA批准，Apitegromab拟于2026年9月30日PDUFA日期登陆美国市场

深圳落地脑机接口数据知识产权登记

占国内近30%！闵行这里凭什么吸引企业和人才？

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/IBRN/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBRN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBRN\",,,,,undefined,":{"symbol":"IBRN","market":"US","secType":"STK","nameCN":"iShares Neuroscience and Healthcare ETF","latestPrice":39.5297,"timestamp":1787601600000,"preClose":39.6482,"halted":0,"volume":982,"hourTrading":{"tag":"盘后","latestPrice":39.45,"preClose":39.5297,"latestTime":"16:10 EDT","volume":6,"amount":237.1782,"timestamp":1787602204712,"change":-0.0797,"changeRate":-0.002016,"amplitude":0},"delay":0,"changeRate":-0.002988786376178603,"floatShares":200000,"shares":200000,"eps":0,"marketStatus":"已收盘","change":-0.1185,"latestTime":"08-24 16:00:00 EDT","open":39.11,"high":39.5297,"low":39.11,"amount":38594,"amplitude":0.010586,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1787644800000},"marketStatusCode":5,"adr":0,"exchange":"ARCA","adjPreClose":39.6482,"sharesOutstanding":150000,"nav":39.601587,"aum":7920317.4,"dividendRate":0.008123,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":39.64,"preClose":39.6482,"latestTime":"09:29 EDT","volume":1,"amount":39.64,"timestamp":1787578185971,"change":-0.0082,"changeRate":-0.000207,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":39.45,"preClose":39.5297,"latestTime":"16:10 EDT","volume":6,"amount":237.1782,"timestamp":1787602204712,"change":-0.0797,"changeRate":-0.002016,"amplitude":0},"volumeRatio":0.496562,"impliedVol":0.0464,"impliedVolPercentile":0.0717},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBRN\",,,,,undefined,":{"symbol":"IBRN","floatShares":200000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.496562,"shares":200000,"dividePrice":0.3211,"high":39.5297,"amplitude":0.010586,"preClose":39.6482,"low":39.11,"week52Low":24.5795,"pbRate":"--","week52High":43.01,"institutionHeld":0,"latestPrice":39.5297,"eps":0,"divideRate":0.008123,"volume":982,"delay":0,"ttmEps":0,"open":39.11,"prevYearClose":32.3193,"prevWeekClose":39.6482,"prevMonthClose":36.6044,"prevQuarterClose":38.8263,"fiveDayClose":39.6414,"twentyDayClose":37.7182,"sixtyDayClose":35.6957},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBRN\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"IBRN","amount":0.319807,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares Neuroscience and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2024-12-17","symbol":"IBRN","amount":0.10114,"announcedDate":"2024-12-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares Neuroscience and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2023-12-20","symbol":"IBRN","amount":0.006303,"announcedDate":"2023-12-19","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"iShares Neuroscience and Healthcare ETF","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"},{"date":"2023-06-07","symbol":"IBRN","amount":0.008241,"announcedDate":"2023-05-12","type":"dividend","market":"US","newRecordDate":"2023-06-08","defaultRemindTime":1686144600000,"name":"iShares Neuroscience and Healthcare ETF","recordDate":"2023-06-13","payableDate":"2023-06-08","currency":"USD","dateTimestamp":1686110400000,"payDate":"2023-06-13"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBRN\",market:\"US\",,,undefined,":[{"executeDate":"2023-06-07","recordDate":"2023-06-08","paymentDate":"2023-06-13","value":0.008241,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-27","value":0.006303,"currency":"USD"},{"executeDate":"2024-12-17","recordDate":"2024-12-17","paymentDate":"2024-12-20","value":0.10114,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-19","value":0.319807,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBRN\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBRN\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662207222","title":"事关人形机器人、脑机接口，工信部征求意见","url":"https://stock-news.laohu8.com/highlight/detail?id=2662207222","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662207222?lang=zh_cn&edition=fundamental","pubTime":"2026-08-25 09:19","pubTimestamp":1787620740,"startTime":"0","endTime":"0","summary":"同日晚间，工信部科技司就《国家脑机接口产业标准体系建设指南》公开向社会征求意见。文件提出，到2028年，制修订脑机接口领域标准40项以上，牵头及参与研制国际标准10项以上，推动超100家企业开展标准宣贯与实施推广。到2030年，累计研制标准80项以上，标准体系基本形成，不断提升我国脑机接口全球标准参与度与产业贡献度。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/t/2026-08-25/doc-inipnuhy5598700.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["RTOO","MNTL","PBOT","IQM","WDRN","ROBT","UBOT","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662043952","title":"首批基金2026年中期报告出炉 看好有色、脑机接口等方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2662043952","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662043952?lang=zh_cn&edition=fundamental","pubTime":"2026-08-25 07:23","pubTimestamp":1787613806,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBRN","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141245521","title":"《柳叶刀·神经病学》刊发阿尔凯默斯Alixorexton治疗1型发作性睡病II期临床积极数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1141245521","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141245521?lang=zh_cn&edition=fundamental","pubTime":"2026-08-25 06:31","pubTimestamp":1787610670,"startTime":"0","endTime":"0","summary":"《柳叶刀·神经病学》杂志近日正式发表了阿尔凯默斯旗下在研药物Alixorexton的Vibrance-1 II期临床研究数据。该研究聚焦于成年1型发作性睡病患者，结果令人振奋。这项研究结果在顶级医学期刊上的亮相，标志着阿尔凯默斯在睡眠障碍治疗领域迈出了坚实一步。Alixorexton作为一种新型治疗手段，其临床数据经过了严格的同行评审，最终获得权威刊物的认可。阿尔凯默斯公司表示，这些积极数据将进一步推动Alixorexton的研发进程，有望为患者带来新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSCH","BK4139","PSIL","IBRN","MEDX","FBT","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661276208","title":"脑机接口保险，从定制到普惠还有多远","url":"https://stock-news.laohu8.com/highlight/detail?id=2661276208","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661276208?lang=zh_cn&edition=fundamental","pubTime":"2026-08-24 20:20","pubTimestamp":1787574000,"startTime":"0","endTime":"0","summary":"从产品属性看，本次脑机接口手术意外险属于面向特定医疗机构、特定术式路径、合规上市植入设备的定向定制方案，并非可以面向全国市场批量投放、通用适配的标准化险种。当手术进入常规临床应用阶段，患者将成为最终付费主体，保费以手术意外险形式纳入整体治疗费用，与当前骨科、心外科手术意外险模式趋同。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-08-24/doc-inipmnpm0046366.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-08-24/doc-inipmnpm0046366.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["MNTL","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661949275","title":"工信部就《国家脑机接口产业标准体系建设指南》公开征求意见。","url":"https://stock-news.laohu8.com/highlight/detail?id=2661949275","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661949275?lang=zh_cn&edition=fundamental","pubTime":"2026-08-24 19:43","pubTimestamp":1787571800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBRN","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661822276","title":"通化金马与宣武医院签署战略合作 推进阿尔茨海默病新药临床与脑卒中管线布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2661822276","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661822276?lang=zh_cn&edition=fundamental","pubTime":"2026-08-24 17:39","pubTimestamp":1787564370,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MNTL","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661228681","title":"联影医疗与天津大学发布全球首个磁共振脑机接口全栈式解决方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2661228681","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661228681?lang=zh_cn&edition=fundamental","pubTime":"2026-08-24 12:53","pubTimestamp":1787547215,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MNTL","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661131243","title":"算力脑机接口接连入局 铁路“跨界”新玩法探路数智化转型","url":"https://stock-news.laohu8.com/highlight/detail?id=2661131243","media":"中国经营报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661131243?lang=zh_cn&edition=fundamental","pubTime":"2026-08-23 22:56","pubTimestamp":1787497016,"startTime":"0","endTime":"0","summary":"8月下旬，两桩来自铁路体系的跨界合作接连落地。8月18日，山东铁路发展基金有限公司（以下简称“山东铁路基金”）与北京硅基流动科技股份有限公司（以下简称“硅基流动”）签署战略合作协议，着手共建“Token工厂”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608233850406145.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608233850406145.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IBRN","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661248485","title":"全国首届磁共振脑机接口大会在津举办","url":"https://stock-news.laohu8.com/highlight/detail?id=2661248485","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661248485?lang=zh_cn&edition=fundamental","pubTime":"2026-08-23 19:17","pubTimestamp":1787483827,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBRN","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661217139","title":"联影、天津大学联合发布全球首个磁共振脑机接口全栈式解决方案uMR神观","url":"https://stock-news.laohu8.com/highlight/detail?id=2661217139","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661217139?lang=zh_cn&edition=fundamental","pubTime":"2026-08-23 12:41","pubTimestamp":1787460101,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IBRN","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661171362","title":"联影、天津大学联合发布全球首个磁共振脑机接口全栈式解决方案uMR神观","url":"https://stock-news.laohu8.com/highlight/detail?id=2661171362","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661171362?lang=zh_cn&edition=fundamental","pubTime":"2026-08-23 12:41","pubTimestamp":1787460076,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MNTL","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661217388","title":"Neko Health 与 Neuralink 合作筛选试验受试者","url":"https://stock-news.laohu8.com/highlight/detail?id=2661217388","media":"链捕手","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661217388?lang=zh_cn&edition=fundamental","pubTime":"2026-08-23 10:03","pubTimestamp":1787450623,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，Neko Health 正与脑机接口公司 Neuralink 开展合作，Neko 将协助筛选 Neuralink 下一轮试验的候选受试者。 ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2284747","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNTL","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661217889","title":"市场消息：Spotify 首席执行官埃克表示，Neko Health 正与脑机接口公司 Neuralink 开展合作。","url":"https://stock-news.laohu8.com/highlight/detail?id=2661217889","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661217889?lang=zh_cn&edition=fundamental","pubTime":"2026-08-23 09:50","pubTimestamp":1787449827,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2265009873.SGD","IBRN","LU2098885051.SGD","BK4548","LU2360107168.USD","SPOG","MNTL","LU1804176565.USD","LU2250418816.HKD","LU1861220033.SGD","LU2362541273.HKD","LU2362540622.SGD","LU2362541513.USD","BK4571","LU0056508442.USD","LU1303367103.USD","LU1983260115.SGD","BK4108","LU2360106780.USD","LU0786609619.USD","LU1852331112.SGD","BK4585","BK4588","SPOT","LU1861215975.USD","LU2290526834.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661729986","title":"Scholar Rock撤回了针对肌肉无力药物的欧洲申报，计划重新提交","url":"https://stock-news.laohu8.com/highlight/detail?id=2661729986","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661729986?lang=zh_cn&edition=fundamental","pubTime":"2026-08-21 22:48","pubTimestamp":1787323684,"startTime":"0","endTime":"0","summary":"Scholar Rock撤回了针对肌肉无力药物的欧洲申报，计划重新提交路透8月21日-Scholar Rock公司SRRK.O周五表示，已撤回其针对一种实验性脊髓性肌萎缩症药物的欧洲上市申请，并计划在诺和诺德旗下工厂出现问题后，选择其他生产基地重新提交申请NOVOb.CO。Scholar Rock表示，公司已将其美国FDA申请中涉及的印第安纳州生产基地移除，并继续预期监管机构将在9月30日的目标行动日期前作出批准决定。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL4T44I0W4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","SRRK","BK4139","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661293498","title":"福瑞医科(300049.SZ)：公司暂无脑机接口的研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2661293498","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661293498?lang=zh_cn&edition=fundamental","pubTime":"2026-08-21 21:17","pubTimestamp":1787318223,"startTime":"0","endTime":"0","summary":"格隆汇8月21日丨福瑞医科(300049.SZ)在投资者互动平台表示，公司暂无脑机接口的研究。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260821/32343226.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0251","BK0028","IBRN","BK0146","300049","BK0096","BK0113","MNTL","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132368667","title":"Scholar Rock控股公司获日本PMDA认可，无需补充临床研究；计划2026年底提交Apitegromab上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1132368667","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132368667?lang=zh_cn&edition=fundamental","pubTime":"2026-08-21 21:12","pubTimestamp":1787317946,"startTime":"0","endTime":"0","summary":"Scholar Rock控股公司迎来重大利好——日本药品和医疗器械管理局（PMDA）已明确表态，认为无需再进行额外的临床研究。这一进展为该公司旗下在研药物Apitegromab的日本上市之路扫清了关键障碍。据此，Scholar Rock计划于2026年底前正式向PMDA提交该药物的上市许可申请（JNDA）。此举标志着公司在全球战略布局中迈出了坚实一步，尤其在亚太核心市场的推进节奏上，展现出明确的执行力与前瞻性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SRRK","THNR","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162355391","title":"Scholar Rock Holding公司撤回欧洲上市申请，计划以替代灌装生产线重新提交","url":"https://stock-news.laohu8.com/highlight/detail?id=1162355391","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162355391?lang=zh_cn&edition=fundamental","pubTime":"2026-08-21 21:12","pubTimestamp":1787317928,"startTime":"0","endTime":"0","summary":"Scholar Rock Holding Corporation宣布，已主动撤回其药物Apitegromab在欧洲的上市许可申请。这一决定并非基于任何安全性或有效性方面的顾虑，而是源于生产环节中的具体问题。公司表示，将转而采用另一条灌装生产线，并计划在调整完成后重新提交申请。Scholar Rock管理层在声明中表达了对项目前景的信心，并承诺将与欧洲监管机构保持密切沟通，以确保后续流程高效推进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SRRK","BK4139","THNR","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158808120","title":"Scholar Rock Holding Corp：蓄势待发，静候FDA批准，Apitegromab拟于2026年9月30日PDUFA日期登陆美国市场","url":"https://stock-news.laohu8.com/highlight/detail?id=1158808120","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158808120?lang=zh_cn&edition=fundamental","pubTime":"2026-08-21 21:10","pubTimestamp":1787317810,"startTime":"0","endTime":"0","summary":"Scholar Rock Holding Corp已经做好全面准备，一旦获得美国食品药品监督管理局的批准，其药物Apitegromab即刻启动在美国市场的上市进程。这一关键节点锁定在2026年9月30日的《处方药使用者付费法案》目标日期。公司上下正厉兵秣马，为这一刻的到来铺平道路。届时，Apitegromab将迅速投放市场，惠及广大患者。这一战略部署彰显了公司对产品获批的坚定信心，也体现了其对市场需求的敏锐把握。随着PDUFA日期的临近，一场精心筹备的市场登陆战即将拉开帷幕。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","SRRK","BK4139","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661260001","title":"深圳落地脑机接口数据知识产权登记","url":"https://stock-news.laohu8.com/highlight/detail?id=2661260001","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661260001?lang=zh_cn&edition=fundamental","pubTime":"2026-08-21 20:19","pubTimestamp":1787314755,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NXTI","PATN","ITAN","IBRN","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661252356","title":"占国内近30%！闵行这里凭什么吸引企业和人才？","url":"https://stock-news.laohu8.com/highlight/detail?id=2661252356","media":"滚动播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661252356?lang=zh_cn&edition=fundamental","pubTime":"2026-08-21 13:30","pubTimestamp":1787290200,"startTime":"0","endTime":"0","summary":"依托新虹桥国际医学中心的优质临床禀赋，闵行全域脑机接口创新企业达到60余家，在国内脑机接口产业领域占比近30%，占全市比例六成以上,闵行没有止步于“建载体、引企业”的传统产业培育路径，而是以机制创新破局，探索形成“医-产-研-企”深度协同的产业培育新范式，推动创新资源从简单叠加走向深度融合，让全国首个脑机接口未来产业集聚区持续释放生长动能。闵行坚持“引育并举、生态留才”，让人才与产业同成长、共发展。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-08-21/doc-inipaent8145486.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IBRN","MNTL"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":1,"totalSize":156,"code":"91000000","status":"200"}]}}